Is Biofil Chemicals And Pharma a good stock to invest in?

Biofil Chemicals And Pharma can be analyzed on the following key metrics - TTM P/E: 154.11 Sector P/E: 26.12 Dividend Yield: 0% D/E ratio: -

Biofil Chemicals And Pharma Share Price

Sector: Biotechnology & Drugs

Powered by

49.50 -1.46 (-2.86%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 46.21

Today’s High 50.96

52 Week Low 40.50

52 Week High 92.00

Key Metrics

Market Cap (In Cr) 81.26
Beta 2.54
Div. Yield (%) 0
P/B 4.4
TTM P/E 154.11
Sector P/E 26.12
Open Price 50.8
Prev Close 50.96

View All Metrics

Biofil Chemicals And Pharma Analysis

Price Analysis

1 Week

7.46%
3 Months

11.28%
6 Month

-21.6%
YTD

-14.29%
1 Year

-22.09%

Risk Meter

49% Low risk
49% Moderate risk
49% Balanced Risk
49% High risk
49% Extreme risk

Biofil Chemicals And Pharma News

Stock market today: Sumeet Bagadia of Choice Broking believes the Nifty 50 index will continue trading positively and touch the immediate target of 25,750 to 25,800. (MINT)

Premium

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy

1 min read . 16 Sep 2024

View More News

Biofil Chemicals And Pharma Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2024

Total Revenue
40.04

Selling/ General/ Admin Expenses Total
0.67

Depreciation/ Amortization
0.4

Other Operating Expenses Total
1.04

Total Operating Expense
39.62

Operating Income
0.42

Net Income Before Taxes
0.87

Net Income
0.71

Diluted Normalized EPS
0.44

Period
2023

Total Revenue
30.04

Selling/ General/ Admin Expenses Total
0.62

Depreciation/ Amortization
0.43

Other Operating Expenses Total
0.82

Total Operating Expense
29.29

Operating Income
0.74

Net Income Before Taxes
0.79

Net Income
0.56

Diluted Normalized EPS
0.34

Period
2022

Total Revenue
22.38

Selling/ General/ Admin Expenses Total
0.79

Depreciation/ Amortization
0.43

Other Operating Expenses Total
0.8

Total Operating Expense
21.48

Operating Income
0.91

Net Income Before Taxes
1.01

Net Income
0.7

Diluted Normalized EPS
0.43

Period
2021

Total Revenue
35.75

Selling/ General/ Admin Expenses Total
0.75

Depreciation/ Amortization
0.41

Other Operating Expenses Total
0.97

Total Operating Expense
34.56

Operating Income
1.19

Net Income Before Taxes
1.92

Net Income
1.24

Diluted Normalized EPS
0.76

Period
2020

Total Revenue
29.69

Selling/ General/ Admin Expenses Total
0.86

Depreciation/ Amortization
0.41

Other Operating Expenses Total
1.7

Total Operating Expense
28.28

Operating Income
1.41

Net Income Before Taxes
1.46

Net Income
1.21

Diluted Normalized EPS
0.74

Period
2019

Total Revenue
23.13

Selling/ General/ Admin Expenses Total
0.89

Depreciation/ Amortization
0.37

Other Operating Expenses Total
1.22

Total Operating Expense
22.47

Operating Income
0.66

Net Income Before Taxes
0.6

Net Income
0.48

Diluted Normalized EPS
0.3

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Biofil Chemicals And Pharma Technical

Moving Average SMA

5 Day46.88
10 Day46.55
20 Day45.17

50 Day44.95
100 Day48.87
300 Day58.17

Biofil Chemicals And Pharma Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Mercury Laboratories
817.6
-13.5
-1.62
1190
736
98.11

Godavari Drugs
99.57
-12.25
-10.96
155
79
74.98

Biofil Chemicals And Pharma
49.5
-1.46
-2.86
92
40.5
81.26

Achyut Healthcare
3.33
-0.06
-1.77
6.25
2.82
78.44

Sunil Healthcare
72
-2.01
-2.72
104
60.55
73.84

Biofil Chemicals And Pharma Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

30-May-25
Audited Results

11-Feb-25
Quarterly Results & Others

14-Nov-24
Quarterly Results

13-Aug-24
Quarterly Results

30-May-24
Audited Results

06-Feb-24
Quarterly Results

09-Nov-23
Quarterly Results

14-Aug-23
Quarterly Results

30-May-23
Audited Results

14-Feb-23
Quarterly Results

Meeting Date
Announced on
Purpose

22-Mar-25
17-Feb-25
POM

30-Sept-24
13-Sept-24
AGM

18-Mar-24
12-Feb-24
POM

27-Sept-23
04-Sept-23
AGM

View All

Company Profile

ABOUT Biofil Chemicals And Pharma

Industry Biotechnology & Drugs
ISIN INE829A01014
BSE Code 524396
NSE Code BIOFILCHEM

Biofil Chemicals and Pharmaceuticals Limited is an India-based company, which is engaged in manufacturing and trading pharmaceutical products. The Company operates through two segments: the Pharmaceutical Division and the Chemicals Division. It is also involved in the business activity of producing plastic products, which are used for the purpose of packing pharmaceutical product and other plastic products. The Company’s product categories include Basic Drugs & Chemicals, and Plastic Dripper & Caps. Its Basic Drugs & Chemicals include Sodium Chloride, Potassium Chloride, Sodium Citrate, Diethyl Carbamazine Citrate, Ferrous Sulphate, Dried Ferrous Sulphate, Ferrus Fumerate, Micro Crystalline Cellulose and Dicyclomine Hydrochloride. The Company's plants are located at Kheda Industrial Estate, Pithampur District, Dhar, and Sanwer Road, Industrial Area, Indore in Madhya Pradesh. The Company also deals in providing job work facilities in respect of the manufacturing of pharmaceutical drugs.

MANAGEMENT

Pavan Rajput Chief Financial Officer
Ketan Shah Whole Time Director

BIOFIL CHEMICALS AND PHARMA SUMMARY

Biofil Chemicals And Pharma is trading 2.86% lower at Rs 49.50 as compared to its last closing price. Biofil Chemicals And Pharma has been trading in the price range of 50.96 & 46.21. Biofil Chemicals And Pharma has given -14.29% in this year & 7.46% in the last 5 days.

Biofil Chemicals And Pharma has TTM P/E ratio 154.11 as compared to the sector P/E of 26.12.

The company posted a net profit of 0.16 Crores in its last quarter.

Listed peers of Biofil Chemicals And Pharma include Mercury Laboratories (-1.62%), Godavari Drugs (-10.96%), Biofil Chemicals And Pharma (-2.86%) etc.

Biofil Chemicals And Pharma has a 46.82% promoter holding & 53.18% public holding.

FAQs about Biofil Chemicals And Pharma

Biofil Chemicals And Pharma is trading at 49.50 as on 30 May, 2025 3:29:13 PM. This is -2.86% lower as compared to its previous closing price of 50.96

The market capitalization of Biofil Chemicals And Pharma is 81.26 Cr as on 30 May, 2025 3:29:13 PM.

The 52 wk high for Biofil Chemicals And Pharma is 92.00 whereas the 52 wk low is 40.50

Biofil Chemicals And Pharma can be analyzed on the following key metrics -

TTM P/E: 154.11
Sector P/E: 26.12
Dividend Yield: 0%
D/E ratio: -

Biofil Chemicals And Pharma reported a net profit of 0.71 Cr in 2024.

Biofil Chemicals And Pharma Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Biofil Chemicals And Pharma Share Price

Price Range

Price Range

Key Metrics

Biofil Chemicals And Pharma Analysis

Biofil Chemicals And Pharma News

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy

Biofil Chemicals And Pharma Financials

Forecast

Forecast

Forecast

Biofil Chemicals And Pharma Technical

Biofil Chemicals And Pharma Peers

Biofil Chemicals And Pharma Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Biofil Chemicals And Pharma

MANAGEMENT

BIOFIL CHEMICALS AND PHARMA SUMMARY

FAQs about Biofil Chemicals And Pharma

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue